|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-4-4
|
|
pubmed:abstractText |
The clinical spectrum, etiologies, and best therapeutic approaches of type II mixed cryoglobulinemia (MC) not associated with hepatitis C virus (HCV) infection have been poorly described to date. We studied the clinical presentation and outcome of patients with type II MC with no evidence of HCV.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
38
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
716-22
|
|
pubmed:meshHeading |
pubmed-meshheading:21239761-Adult,
pubmed-meshheading:21239761-Aged,
pubmed-meshheading:21239761-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:21239761-Cryoglobulinemia,
pubmed-meshheading:21239761-Female,
pubmed-meshheading:21239761-Hepatitis C,
pubmed-meshheading:21239761-Humans,
pubmed-meshheading:21239761-Immunologic Factors,
pubmed-meshheading:21239761-Male,
pubmed-meshheading:21239761-Middle Aged,
pubmed-meshheading:21239761-Retrospective Studies,
pubmed-meshheading:21239761-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Clinical spectrum, treatment, and outcome of patients with type II mixed cryoglobulinemia without evidence of hepatitis C infection.
|
|
pubmed:affiliation |
Department of Clinical Immunology, National Referral Center or Autoimmune Diseases, University of Strasbourg, Strasbourg, France.
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|
